Investors / Taiwan / AMED Ventures
AMED Ventures
Venture capital · Taipei, Taiwan · Asia Pacific
AMED Ventures is a venture and growth capital firm focused on the MedTech sector, with offices in Taipei, Taiwan and Fremont, California. It invests across the MedTech landscape, from medical devices to advanced contract manufacturing, and works with founders through value-chain collaboration and industry partnerships.
Invests inHealthcare & Biotech
In its own wordsmedtechmedical deviceshealthcarecontract manufacturing
Your fit with AMED Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsAMED Ventures lists 17 checked portfolio companies on its own site and is named in 5 funding rounds, 1 of them as lead. Its most frequent entry is Series B, 100% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 85% of its companies are based in United States. It invests most often alongside Ascension Ventures, Delos Capital and Techlink Ventures.
Counts come from funding rounds that name AMED Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not AMED Ventures' whole history. Rounds on record name 5 companies; its own site lists 17. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundAMED Ventures does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 0% |
| Series B | 100% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 1 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 2 | 0 |
| '26 | 2 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 44th | 17 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 66th | 6% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 42th | 2 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Ascension Ventures | 4 |
| Delos Capital | 4 |
| Techlink Ventures | 4 |
| Unorthodox Ventures | 3 |
| 415 Capital | 2 |
| FemHealth Ventures | 2 |
| Catalio Capital Management | 1 |
| Catalyst Health Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers17100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Ascension Ventures
Compare AMED Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with AMED Ventures| Date | Company | Stage |
|---|---|---|
| 4 Nov 2026 | Series B | |
| 24 Mar 2026 | Round Led | |
| 3 Oct 2025 | Series B | |
| 7 Dec 2022 | Series B |
Round details for AMED Ventures
Amounts, full round histories and every co-investor in AMED Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
17 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Adona Medical develops a novel interatrial shunt for the management of heart failure | Healthcare & Biotech | Portfolio page | ||
| Akura Medical develops medical devices for treating venous thromboembolism | Healthcare & Biotech | Oct 2025Series B | Funding round | |
| Akura Medical develops medical devices, such as the Katana Thrombectomy System, to treat venous thromboembolism. | Healthcare & Biotech | Portfolio page | ||
| Benthic Genomics converts complex genomic regions into crisp, actionable, and high-confidence genomic calls at higher precision and scale compared to standard microarray and NGS methods. | Healthcare & Biotech | Portfolio page | ||
| Dynaflex Technologies provides catheter and extrusion solutions | Healthcare & Biotech | Portfolio page | ||
| EpiFrontier is a biotechnology company developing oral therapies for hemoglobinopathies. | Healthcare & Biotech | Mar 2026Round | Funding round | |
| Imperative Care develops and provides medical solutions for patients with stroke and other vascular diseases. | Healthcare & Biotech | Portfolio page | ||
| Instylla develops novel resorbable embolic agents to advance interventional radiology, with initial clinical applications in interventional oncology. | Healthcare & Biotech | Portfolio page | ||
| Kandu delivers a first-of-its-kind approach to stroke recovery using IpsiHand brain-computer interface therapy | Healthcare & Biotech | Portfolio page | ||
| KT Medical Inc. produces medical grade wires and components for various medical applications. | Healthcare & Biotech | Portfolio page | ||
| Laza Medical is developing an intelligent imaging system to simplify cardiac procedures | Healthcare & Biotech | Nov 2026Series B | Funding round | |
| Rejoni is involved in uterine health | Healthcare & Biotech | Dec 2022Series B | Page + round | |
| Supira Medical is developing a next-generation percutaneous ventricular assist device for use in high-risk patients undergoing interventional procedures or experiencing cardiogenic shock. | Healthcare & Biotech | Portfolio page | ||
| Tioga Cardiovascular shapes the future of complex cardiovascular procedures using physical AI, closed-loop navigation, and modular robotics. | Healthcare & Biotech | Portfolio page | ||
| Tulavi develops solutions for peripheral nerve surgery, including a fully absorbable hydrogel cap to reduce the risk of symptomatic neuroma formation. | Healthcare & Biotech | Portfolio page | ||
| Verge Medical develops and commercializes medical technology solutions for aorto-ostial interventions. | Healthcare & Biotech | Portfolio page | ||
| Wiltrom develops and manufactures medical devices, including spinal fusion systems and vertebral body augmentation systems. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- amedventures.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 7 Dec 2022
- Companies checked
- 17
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get AMED Ventures' profile as data
Pull AMED Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/amedventures.com
# also
GET /v1/firms/amedventures.com/portfolio
GET /v1/firms/amedventures.com/coinvestors
GET /v1/firms/amedventures.com/news